Described herein are pharmaceutical packaging devices which reduce oxidative degradation of morphine, hydromorphone, promethazine along with other oxygen-delicate medicine, this sort of programs which includes a syringe having an oxygen permeable idea cap, a hermetically sealed oxygen barrier bliste